International Biotechnology Trust PLC Amarin Corp Plcuk Transaction History
International Biotechnology Trust PLC
- $295 Million
- Q3 2023
Shares
6 transactions
Others Institutions Holding AMRN
# of Institutions
139Shares Held
68.2MCall Options Held
133KPut Options Held
26.4K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$386 Million60.8% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$193 Million9.37% of portfolio
-
Acadian Asset Management LLC Boston, MA3.79MShares$59 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY3.4MShares$52.9 Million3.37% of portfolio
-
Morgan Stanley New York, NY2.62MShares$40.8 Million0.0% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $6.27B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...